Cargando…

Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is a malignant tumor originating from proximal tubular epithelial cells, and despite extensive research efforts, its redox homeostasis characteristics and protein S-nitrosylation (or S-nitrosation) (SNO) modification remain largely undefined. This serves as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Qiao, Xinhua, Xie, Ting, Cai, Wenbin, Zhang, Xu, Chen, Chang, Zhang, Yaoguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854847/ https://www.ncbi.nlm.nih.gov/pubmed/36670943 http://dx.doi.org/10.3390/antiox12010081

Ejemplares similares

Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
por: Jiang, Yuxiong, et al.
Publicado: (2022)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

The Association of Polymorphisms in Nrf2 and Genes Involved in Redox Homeostasis in the Development and Progression of Clear Cell Renal Cell Carcinoma
por: Mihailovic, Smiljana, et al.
Publicado: (2021)

Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma
por: Zheng, Wenzhong, et al.
Publicado: (2021)

Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma
por: Wei, Xiangling, et al.
Publicado: (2022)

Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022)

Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma
por: Zhao, Enyang, et al.
Publicado: (2019)

Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis
por: Liu, Pengfei, et al.
Publicado: (2020)

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
por: Zhu, Maoshu, et al.
Publicado: (2023)

Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation
por: Mitchell, Wayne, et al.
Publicado: (2023)

Direct cardiac reprogramming: Toward the era of multi-omics analysis
por: Liu, Mengxin, et al.
Publicado: (2022)

Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma
por: Zhao, Junjie, et al.
Publicado: (2022)

Role of Metabolic Reprogramming of Long non-coding RNA in Clear Cell Renal Cell Carcinoma
por: Zhang, Huijie, et al.
Publicado: (2022)

Multi-omic rejuvenation of human cells by maturation phase transient reprogramming
por: Gill, Diljeet, et al.
Publicado: (2022)

m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma
por: Ma, Tianming, et al.
Publicado: (2022)

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
por: Zhong, Weimin, et al.
Publicado: (2021)

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
por: Xu, Jiahao, et al.
Publicado: (2022)

Multi-omics analysis explores the effect of chronic exercise on liver metabolic reprogramming in mice
por: Lu, Zhaoxu, et al.
Publicado: (2023)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
por: Wang, Xuechun, et al.
Publicado: (2022)

The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2016)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
por: Chang, Kun, et al.
Publicado: (2022)

Multi-omics Analysis of Prognostic Significance and Immune Infiltration of FASTK Family Members in Kidney Renal Clear Cell Carcinoma
por: Zhong, Guanghui, et al.
Publicado: (2023)

The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma
por: Yang, Yang, et al.
Publicado: (2023)

Sex differences in redox homeostasis in renal disease
por: Mitchell, Tanecia, et al.
Publicado: (2020)

Prognostic value of cross-omics screening for kidney clear cell renal cancer survival
por: Dimitrieva, Slavica, et al.
Publicado: (2016)

Multi-omics analysis reveals the effects of microbiota on oral homeostasis
por: Long, Huiqing, et al.
Publicado: (2022)

Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma
por: Song, Jing, et al.
Publicado: (2019)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)
por: Zeng, Xing, et al.
Publicado: (2022)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Three novel hub genes and their clinical significance in clear cell renal cell carcinoma
por: Xiao, He, et al.
Publicado: (2019)

The Redox Homeostasis of Skeletal Muscle Cells Regulates Stage Differentiation of Toxoplasma gondii
por: Rahman, Md. Taibur, et al.
Publicado: (2021)

Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2020)

Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)

Multi-Omics Studies Demonstrate Toxoplasma gondii-Induced Metabolic Reprogramming of Murine Dendritic Cells
por: Hargrave, Kerrie E., et al.
Publicado: (2019)

A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application
por: Zhang, Qian, et al.
Publicado: (2022)

Regulation of Cell Transformation by Rb-Controlled Redox Homeostasis
por: Zhu, Zhongling, et al.
Publicado: (2014)

Energy and Redox Homeostasis in Tumor Cells
por: de Oliveira, Marcus Fernandes, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sven6fsbopdi51t744o91liavc